ADMA BIOLOGICS INC - COMMON STOCK
19.61
15-November-24 10:07:23
15 minutes delayed
Stocks
-0.59
-2.92%
Today's range
19.56 - 20.34
ISIN
N/A
Source
NASDAQ
-
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
09 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
02 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update
10 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Addition to the Russell 2000® Index
21 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update
11 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
04 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
01 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
24 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
21 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
07 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
19 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
18 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
21 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Provides Update on Global Intellectual Property Portfolio
09 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
17 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
16 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
10 Nov 2021 16:01:01 By Nasdaq GlobeNewswire